SEARLE & CO. RPRX — ROYALTY PHARMA PLC

Ownership history in SEARLE & CO.  ·  7 quarters on record

AI Ownership Summary

SEARLE & CO. reported ROYALTY PHARMA PLC (RPRX) in 7 quarterly 13F filings from 2024 Q2 through 2025 Q4. Peak portfolio weight reached 0.59% in 2025 Q2. The latest visible filing shows RPRX at 0.57% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this RPRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SEARLE & CO.'s position in ROYALTY PHARMA PLC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

RPRX was reported at 0.57% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.59% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

RPRX stock page SEARLE & CO. fund profile SEARLE & CO. full holdings
How SEARLE & CO. held RPRX — position size vs. price
% of Fund (quarterly)    RPRX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED — — — 57,500 — 0% 0.57% $2.2M 2026-02-14 (Est.) $44.95
2025 Q3 UNCHANGED — — — 57,500 — 0% 0.54% $2.0M 2025-11-04 $37.43
2025 Q2 UNCHANGED — — — 57,500 — 0% 0.59% $2.1M 2025-08-07 $36.39
2025 Q1 UNCHANGED — — — 57,500 — 0% 0.51% $1.8M 2025-05-15 $32.35
2024 Q4 UNCHANGED — — — 57,500 — 0% 0.42% $1.5M 2025-02-14 $31.40
2024 Q3 UNCHANGED — — — 57,500 — 0% 0.41% $1.6M 2024-10-22 $26.34
2024 Q2 INITIATED — — — 57,500 — — 0.36% $1.5M 2024-07-30 $27.26

🏢 Other funds also holding RPRX

As of 2026 Q1 — sorted by position size

TORRAY INVESTMENT PARTNERS LLC 3Y 7Y 4.54% COOPER INVESTORS PTY LTD 4.14% KIRR MARBACH & CO LLC /IN/ 3Y 7Y 2.08% Goodman Advisory Group, LLC 3Y 2.07% Kearns & Associates LLC 3Y 1.5% S&CO INC 3Y 7Y 1.07% Aurora Investment Counsel 3Y 7Y 0.94% Hosking Partners LLP 3Y 7Y 0.86% Marathon Asset Management Ltd 3Y 0.81% COOKSON PEIRCE & CO INC 3Y 7Y 0.79%

FAQ About SEARLE & CO. and RPRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has SEARLE & CO. reported owning RPRX?

SEARLE & CO. reported RPRX across 7 quarterly 13F filings, from 2024 Q2 through 2025 Q4.

What was the largest reported RPRX position in SEARLE & CO.'s portfolio?

The largest reported portfolio weight for RPRX was 0.59% in 2025 Q2.

What is the latest reported RPRX position on this page?

The most recent filing on this page is 2025 Q4, when SEARLE & CO. reported 57,500 shares, equal to 0.57% of portfolio, with an estimated market value of $2.2M.

What does the chart on this RPRX ownership page compare?

The chart compares SEARLE & CO.'s quarterly RPRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to SEARLE & CO. Holdings